Positive clues to identifying a rare disease 

 

Congenital Sucrase-isomaltase Deficiency (CSID) is a rare but debilitating disease that first manifests in childhood, but often goes misdiagnosed as toddler’s diarrhea, or in adults, as multiple other GI disorders. 

 

Nukleus helped QOL give healthcare professionals a better set of clues to diagnose CSID—and helped QOL to focus their communication efforts on improving diagnosis first before talking about treatment. The goal was to help clinicians better understand CSID, reach a proper diagnosis with a simple, inexpensive breath test and genetic swab combination approach, and eventually successfully treat it. Nukleus created custom dietary, educational materials and targeted pediatric and adult campaigns to set everyone on the right path.